Forvisirvat
Jump to navigation
Jump to search
| File:Forvisirvat.svg | |
| Clinical data | |
|---|---|
| Other names | SP624 |
| Routes of administration | Oral[1] |
| Drug class | Sirtuin-6 (SIRT6) activator[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| E number | {{#property:P628}} |
| CompTox Dashboard (EPA) |
|
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 29: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C19H17ClN2O6 |
| Molar mass | 404.80 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Forvisirvat (INN, USAN; developmental code name SP-624) is a sirtuin-6 (SIRT6) activator which is under development for the treatment of major depressive disorder and schizophrenia.[1][2][3][4][5] It is taken by mouth.[1] As of January 2025, forvisirvat is in phase 2/3 clinical trials for major depressive disorder and is in phase 1/2 clinical trials for schizophrenia.[1][2][4] It is under development by Sirtsei Pharmaceuticals and Arrivo BioVentures.[1][2][5]
See also
[edit | edit source]References
[edit | edit source]- ^ a b c d e f Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
- ^ a b c Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
- ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
- ^ a b Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
- ^ a b Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).